WuXi XDC’s Post

View organization page for WuXi XDC, graphic

9,243 followers

On August 21, 2024, Fortune announced its inaugural "2024 Fortune China Technology 50" list. Recognizing WuXi XDC (Stock Code: 2268.HK), a global leader in end-to-end CRDMO services focused on Antibody-Drug Conjugates (ADCs) and other bioconjugates, for its exceptional innovation capabilities and global impact. This recognition underscores the company's comprehensive, bioconjugate drug development services, its world-class integrated technology platform, and its strong potential for future growth.   According to Fortune, “The company has consistently pushed the boundaries of what's possible in the development and manufacturing of bioconjugates, offering clients a comprehensive suite of services that accelerate the journey from concept to commercialization. ”

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics